Literature DB >> 1669697

Expression of adhesion molecules and histocompatibility antigens at the blood-brain barrier.

H Lassmann1, K Rössler, F Zimprich, K Vass.   

Abstract

The migration of inflammatory cells through the blood-brain barrier in health and disease involves complex interactions between hematogenous cells, endothelial cells, the basement membrane and the perivascular glia limitans. Recent evidence is presented, suggesting that part of these interactions involve antigen independent mechanisms, mediated by cellular adhesion molecules. The accessibility of endothelial adhesion molecules in the intact blood-brain barrier is lower compared to vessels in other organs. This may account for the low traffic of hematogenous cells through the normal blood-brain barrier. However, in inflammatory conditions the expression of endothelial adhesion molecules is upregulated, which may lead to recruitment of inflammatory cells into the lesions. Antigen specific activation of T-cells at the blood-brain barrier apparently takes place mainly at perivascular monocytes and microglia cells. In severe inflammatory lesions, however, astrocytes may be additionally involved in antigen presentation.

Mesh:

Substances:

Year:  1991        PMID: 1669697     DOI: 10.1111/j.1750-3639.1991.tb00648.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.

Authors:  Raktima Bhattacharya; Yan Xu; Md Ashequr Rahman; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Jon A Weidanz; Ulrich Bickel
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.

Authors:  M Montesinos-Rongen; R Küppers; D Schlüter; T Spieker; D Van Roost; C Schaller; G Reifenberger; O D Wiestler; M Deckert-Schlüter
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain.

Authors:  M Schmied; H Breitschopf; R Gold; H Zischler; G Rothe; H Wekerle; H Lassmann
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

4.  Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor.

Authors:  A K Stalder; M J Carson; A Pagenstecher; V C Asensio; C Kincaid; M Benedict; H C Powell; E Masliah; I L Campbell
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

6.  L3T4(CD4)-, Lyt-2(CD8)- and Mac-1(CD11b)-phenotypic leukocytes in murine cryptococcal meningoencephalitis.

Authors:  P Dobrick; K Miksits; H Hahn
Journal:  Mycopathologia       Date:  1995-09       Impact factor: 2.574

7.  Strain-specific variation in constitutive and inducible expression of MHC class II, class I and ICAM-1 on rat cerebral endothelium.

Authors:  A T Linke; D K Male
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

8.  Lymphocyte migration into the CNS modelled in vitro: roles of LFA-1, ICAM-1 and VLA-4.

Authors:  D Male; J Rahman; G Pryce; T Tamatani; M Miyasaka
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

9.  Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat.

Authors:  Monica R Hazelrigg; Jerry I Hirsch; Randall E Merchant
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

Review 10.  Microglial Phenotypes and Functions in Multiple Sclerosis.

Authors:  Elaine O'Loughlin; Charlotte Madore; Hans Lassmann; Oleg Butovsky
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.